Modified Tarsorrhaphy vs Gold Weight Implant for Paralytic Lagophthalmos in Leprosy Patients

This study aims to compare the effectivity and efficiency of Modified Tarsorrhaphy (MT) technique and Gold Weight Implant (GWI) technique as a surgical treatment of paralytic lagophthalmos in leprosy ...

Lead sponsor: Yunia Irawati•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Self-Adhering Magnetic Device to Treat Corneal Exposure

NCT06291818 · Paralytic Lagophthalmos, Corneal Exposure

Not Yet Recruiting

Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Hansen's Disease in Costa Rica (2018-2025)

NCT07448389 · Leprosy, Hansen's Disease, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 29, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment19

Start dateMay 2019

Last updatedJun 29, 2021

Condition

Paralytic Lagophthalmos Leprosy--Patients

Locations shown

Jakarta Eye Center Hospitals and Clinics

Jakarta, DKI Jakarta

dr. Cipto Mangunkusumo Kirana Eye Hospital

Jakarta Pusat, DKI Jakarta

dr. Tadjuddin Chalid General Hospital

Makassar, South Sulawesi

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 29, 2021Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions